Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Medpace Holdings Inc (MEDP) vs IAC/Interactivecorp (PPLI) Price & Performance

Medpace Holdings IncTrade
IAC/InteractivecorpTrade

Price performance (Past 24H)

Key statistics

Medpace Holdings Inc vs IAC/Interactivecorp — how do they compare? Medpace Holdings Inc trades at $533.1 (market cap $15.08B), while IAC/Interactivecorp trades at $44.18 (market cap $3.32B). The key difference: Medpace Holdings Inc is far larger — about 4.5× IAC/Interactivecorp's market cap. Which is the better fit depends on your goals.

MEDPPPLI
Market Cap
$15.08B$3.32B
Sector
TechnologyMedia
52-Week High
$620.59$47.62
52-Week Low
$308.88$31.52
Enterprise Value
$14.55B$3.63B

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Medpace Holdings Inc

MEDP trades at $527.93, down 1.82% today, with a bullish technical outlook supported by moving averages. The company demonstrates strong profitability with 17.19% net margins and 77.25% ROE, though valuation ratios appear elevated with a P/E of 33.83. Recent earnings have consistently beaten expectations, and cash flow is projected to improve significantly in 2026. However, the stock faces headwinds from ongoing class action lawsuits and mixed analyst sentiment with 73.69% hold ratings.

MEDP presents a mixed investment case with strong fundamental performance offset by legal overhangs and premium valuation. The company's consistent earnings beats and projected cash flow improvement support upside potential, but investors should weigh the legal risks and cautious analyst stance against the robust operational metrics.

IAC/Interactivecorp

PPLI trades at $44.71, up 0.4% today, with a bullish technical signal from moving averages and oversold short-term RSI. Recent quarters show earnings misses, but revenue stabilized near $2.4B in 2025. The stock trades below book value (P/B 0.73) and carries a consensus price target of $55.40. News highlights potential MGM acquisition talks and Q2 2026 earnings call scheduled for August 4th.

Outlook is mixed: strong analyst buy ratings (64%) and undervaluation signals support upside, but persistent net losses and volatile cash flows pose risks. Investors should weigh the discount to NAV against execution challenges in achieving profitability.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Medpace Holdings Inc

Medpace Holdings, Inc. is a full-service clinical contract research organization (CRO) that provides comprehensive and scientifically-driven clinical development services to the biotechnology, pharmaceutical, and medical device industries. The company specializes in conducting global clinical trials for new drug and medical device approvals. Medpace's model emphasizes therapeutic expertise and a highly integrated approach to accelerate the clinical development process for its clients.

Read more on MEDP

About IAC/Interactivecorp

IAC Inc is an Internet media company with segments that include Angi (47% of total revenue), Dotdash (10%), search (24%), and emerging and other (19%). The firm spun off the narrow-moat dating app provider Match Group in second-quarter 2020 and the no-moat video software provider Vimeo in second-quarter 2021.

Read more on PPLI